CL
GSK icon

CSS LLC’s GSK GSK Stock Holding History

CSS LLC’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,000
Closed -$429K – 940
2024
Q1 		$429K Buy
+10,000
New +$412K 0.02% 492

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CSS LLC's GSK Position: Q3 2025 in Review

CSS LLC sold out of GSK (GSK) in Q3 2025, closing a stake of 9,230 shares — an estimated $354K sold.

CSS LLC first reported a position in GSK in Q1 2024 and held it in 6 quarters. The position peaked at $1.1M in Q4 2024. 895 funds tracked by Wall St. Rank hold GSK as of Q3 2025.

  • CSS LLC reported no remaining GSK position as of Q3 2025 after selling out during the quarter.
  • CSS LLC sold 9,230 GSK shares in Q3 2025, an estimated $354K.
  • CSS LLC first reported a position in GSK in Q1 2024 and held it in 6 quarters.
  • CSS LLC's GSK position peaked at $1.1M in Q4 2024.
  • 895 funds tracked by Wall St. Rank held GSK as of Q3 2025.

Based on CSS LLC's 13F filing for Q3 2025, filed 13 Nov 2025.